Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Winhealth to Market Two Cumberland Pharma Pain Drugs in China

publication date: May 15, 2019

China's Winhealth Pharma has in-licensed greater China rights for two FDA approved pain management drugs from Cumberland Pharma. Winhealth will have rights to distribute Acetadote® (acetylcysteine) Injection, used to treat liver damage from acetaminophen overdose, and Caldolor® (ibuprofen) Injection, used to treat pain and fever in hospitals. Winhealth currently markets 12 pharmaceutical products in China via partnerships with multinational pharmas and other companies. Established in 2006, Winhealth was founded in Hangzhou and now has its headquarters in Hong Kong. More details....

Stock Symbol: (NSDQ: CPIX)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China